A RetroSearch Logo

Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Search Query:

Showing content from https://pubmed.ncbi.nlm.nih.gov/35797056/ below:

Global Association of COVID-19 Pandemic Measures With Cancer Screening: A Systematic Review and Meta-analysis

Meta-Analysis

. 2022 Sep 1;8(9):1287-1293. doi: 10.1001/jamaoncol.2022.2617. Global Association of COVID-19 Pandemic Measures With Cancer Screening: A Systematic Review and Meta-analysis

Affiliations

Affiliations

Item in Clipboard

Meta-Analysis

Global Association of COVID-19 Pandemic Measures With Cancer Screening: A Systematic Review and Meta-analysis

Federica Teglia et al. JAMA Oncol. 2022.

. 2022 Sep 1;8(9):1287-1293. doi: 10.1001/jamaoncol.2022.2617. Affiliations

Item in Clipboard

Abstract

Importance: Public health services, including cancer screening tests, have been affected by the onset of the COVID-19 epidemic.

Objective: To investigate the pandemic's association with cancer screening worldwide.

Data sources: In this systematic review and meta-analysis, databases such as PubMed, ProQuest, and Scopus were searched comprehensively for articles published between January 1, 2020, and December 12, 2021.

Study selection: Observational studies and articles that reported data from cancer registries that compared the number of screening tests performed before and during the pandemic for breast, cervical, and colorectal cancer were included.

Data extraction and synthesis: Two pairs of independent reviewers extracted data from the selected studies. The weighted average of the percentage variation was calculated between the 2 periods to assess the change in the number of cancer screening tests performed during the pandemic. Stratified analysis was performed by geographic area, period, and type of setting. The systematic review and meta-analysis was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guideline.

Main outcomes and measures: The main outcome was the weighted average percentage variation in the number of screening tests performed between January and October 2020 compared with the previous period.

Results: The review comprised 39 publications. There was an overall decrease of -46.7% (95% CI, -55.5% to -37.8%) for breast cancer screening, -44.9% (95% CI, -53.8% to -36.1%) for colorectal cancer screening, and -51.8% (95% CI, -64.7% to -38.9%) for cervical cancer screening during the pandemic. For all 3 cancers, a U-shaped temporal trend was identified; for colorectal cancer, a significant decrease was still apparent after May 2020 (in June to October, the decrease was -23.4% [95% CI, -44.4% to -2.4%]). Differences by geographic area and screening setting were also identified.

Conclusions and relevance: A summary estimate of the downscaling of cancer screening tests since the onset of the COVID-19 pandemic is provided in this systematic review and meta-analysis. This could be associated with an increase in the number of avoidable cancer deaths. Effective interventions are required to restore the capacity of screening services to the prepandemic level.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure 1.. PRISMA (Preferred Reporting Items for…

Figure 1.. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) Flow Diagram of Information…

Figure 1.. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) Flow Diagram of Information Through the Various Phases of the Systematic Review

Figure 2.. Weighted Average Variation of Screening…

Figure 2.. Weighted Average Variation of Screening Tests Performed From January to October 2020 Compared…

Figure 2.. Weighted Average Variation of Screening Tests Performed From January to October 2020 Compared With the Prepandemic Period, by Cancer Type and Period Similar articles Cited by References
    1. Sung H, Ferlay J, Siegel RL, et al. . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249. doi:10.3322/caac.21660 - DOI - PubMed
    1. Canfell K, Kim JJ, Brisson M, et al. . Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020;395(10224):591-603. doi:10.1016/S0140-6736(20)30157-4 - DOI - PMC - PubMed
    1. Ortiz AP, Gierbolini-Bermúdez A, Ramos-Cartagena JM, et al. . Cervical cancer screening among Medicaid patients during natural disasters and the COVID-19 pandemic in Puerto Rico, 2016 to 2020. JAMA Netw Open. 2021;4(10):e2128806. doi:10.1001/jamanetworkopen.2021.28806 - DOI - PMC - PubMed
    1. Sharma KA, Zangmo R, Kumari A, Roy KK, Bharti J. Family planning and abortion services in COVID 19 pandemic. Taiwan J Obstet Gynecol. 2020;59(6):808-811. doi:10.1016/j.tjog.2020.09.005 - DOI - PMC - PubMed
    1. Stover J, Kelly SL, Mudimu E, et al. . The risks and benefits of providing HIV services during the COVID-19 pandemic. PLoS One. 2021;16(12):e0260820. doi:10.1371/journal.pone.0260820 - DOI - PMC - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3